327 related articles for article (PubMed ID: 9475021)
21. Efficacy of mipragoside ophthalmic gel in vernal keratoconjunctivitis.
Centofanti M; Schiavone M; Lambiase A; Taffara M; Giuffrida S; Bonini S
Eye (Lond); 1996; 10 ( Pt 4)():422-4. PubMed ID: 8944090
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of nonpreserved ketorolac ophthalmic solution in postoperative ocular pain following radial keratotomy.
Brint SF; Cheetham JK; DeGryse R; Abel ML; Thompson VM; Rosenthal A
J Cataract Refract Surg; 1999 Jan; 25(1):41-9. PubMed ID: 9888075
[TBL] [Abstract][Full Text] [Related]
23. A randomized trial of topical cyclosporin 0.05% in topical steroid-resistant atopic keratoconjunctivitis.
Akpek EK; Dart JK; Watson S; Christen W; Dursun D; Yoo S; O'Brien TP; Schein OD; Gottsch JD
Ophthalmology; 2004 Mar; 111(3):476-82. PubMed ID: 15019322
[TBL] [Abstract][Full Text] [Related]
24. Ketorolac tromethamine in the maintenance of intraoperative mydriasis.
Gupta VP; Dhaliwal U; Prasad N
Ophthalmic Surg Lasers; 1997 Sep; 28(9):731-8. PubMed ID: 9304635
[TBL] [Abstract][Full Text] [Related]
25. Safety and efficacy of ketorolac tromethamine 0.4% ophthalmic solution in post-photorefractive keratectomy patients.
Solomon KD; Donnenfeld ED; Raizman M; Sandoval HP; Stern K; VanDenburgh A; Cheetham JK; Schiffman R;
J Cataract Refract Surg; 2004 Aug; 30(8):1653-60. PubMed ID: 15313287
[TBL] [Abstract][Full Text] [Related]
26. A randomized, double-masked, placebo-controlled parallel study of loteprednol etabonate 0.2% in patients with seasonal allergic conjunctivitis.
Shulman DG; Lothringer LL; Rubin JM; Briggs RB; Howes J; Novack GD; Hart K
Ophthalmology; 1999 Feb; 106(2):362-9. PubMed ID: 9951491
[TBL] [Abstract][Full Text] [Related]
27. A randomized, placebo-controlled trial of topical cyclosporin A in steroid-dependent atopic keratoconjunctivitis.
Hingorani M; Moodaley L; Calder VL; Buckley RJ; Lightman S
Ophthalmology; 1998 Sep; 105(9):1715-20. PubMed ID: 9754182
[TBL] [Abstract][Full Text] [Related]
28. Comparative study of ketorolac and dipyrone in the treatment of postoperative pain.
Ibarra-Ibarra LG; Cubillo MA; Silva-Adaya A; González-García CA
Proc West Pharmacol Soc; 1993; 36():133-5. PubMed ID: 8378366
[No Abstract] [Full Text] [Related]
29. Evaluation of periapical injection of Ketorolac for management of endodontic pain.
Penniston SG; Hargreaves KM
J Endod; 1996 Feb; 22(2):55-9. PubMed ID: 8935018
[TBL] [Abstract][Full Text] [Related]
30. [Cyclosporin A 2% eyedrops in therapy of atopic and vernal keratoconjunctivitis].
Tomida I; Schlote T; Bräuning J; Heide PE; Zierhut M
Ophthalmologe; 2002 Oct; 99(10):761-7. PubMed ID: 12376851
[TBL] [Abstract][Full Text] [Related]
31. [Effects levocabastine ophthalmic solution (H1 receptor antagonist) on symptoms of vernal conjunctivitis. A prospective, randomized double-blind study].
Graue E
Gac Med Mex; 1994; 130(6):481-6. PubMed ID: 7557064
[TBL] [Abstract][Full Text] [Related]
32. The use of topical ketorolac 0.5% for pain relief following cyclophotocoagulation.
Birt CM
Ophthalmic Surg Lasers Imaging; 2003; 34(5):381-5. PubMed ID: 14509461
[TBL] [Abstract][Full Text] [Related]
33. Ketorolac treatment of pseudophakic cystoid macular edema identified more than 24 months after cataract extraction.
Weisz JM; Bressler NM; Bressler SB; Schachat AP
Ophthalmology; 1999 Sep; 106(9):1656-9. PubMed ID: 10485530
[TBL] [Abstract][Full Text] [Related]
34. Topical and oral ketorolac administration increases the intraocular pressure-lowering effect of latanoprost.
Costagliola C; Campa C; Perri P; Parmeggiani F; Romano MR; Incorvaia C
Curr Eye Res; 2008 May; 33(5):477-82. PubMed ID: 18568885
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and comfort of olopatadine 0.2% versus epinastine 0.05% ophthalmic solution for treating itching and redness induced by conjunctival allergen challenge.
Mah FS; Rosenwasser LJ; Townsend WD; Greiner JV; Bensch G
Curr Med Res Opin; 2007 Jun; 23(6):1445-52. PubMed ID: 17559743
[TBL] [Abstract][Full Text] [Related]
36. A randomized trial of low-dose, topical mitomycin-C in the treatment of severe vernal keratoconjunctivitis.
Akpek EK; Hasiripi H; Christen WG; Kalayci D
Ophthalmology; 2000 Feb; 107(2):263-9. PubMed ID: 10690822
[TBL] [Abstract][Full Text] [Related]
37. Effectiveness of nedocromil sodium 2% eyedrops on clinical symptoms and tear fluid cytology of patients with vernal conjunctivitis.
Bonini S; Barney NP; Schiavone M; Centofanti M; Berruto A; Bonini S; Allansmith MR
Eye (Lond); 1992; 6 ( Pt 6)():648-52. PubMed ID: 1337745
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of olopatadine HCI 0.1%, ketotifen fumarate 0.025%, epinastine HCI 0.05%, emedastine 0.05% and fluorometholone acetate 0.1% ophthalmic solutions for seasonal allergic conjunctivitis: a placebo-controlled environmental trial.
Borazan M; Karalezli A; Akova YA; Akman A; Kiyici H; Erbek SS
Acta Ophthalmol; 2009 Aug; 87(5):549-54. PubMed ID: 18631332
[TBL] [Abstract][Full Text] [Related]
39. Nedocromil sodium 2% ophthalmic solution for the treatment of ragweed pollen seasonal allergic conjunctivitis.
Blumenthal MN; Schwartz RH; Kaiser H
Ocul Immunol Inflamm; 2000 Sep; 8(3):159-67. PubMed ID: 11120577
[TBL] [Abstract][Full Text] [Related]
40. Preservative-free diclofenac sodium 0.1% for vernal keratoconjunctivitis.
D'Angelo G; Lambiase A; Cortes M; Sgrulletta R; Pasqualetti R; Lamagna A; Bonini S
Graefes Arch Clin Exp Ophthalmol; 2003 Mar; 241(3):192-5. PubMed ID: 12644942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
